Discover 661 paid clinical trials in Sheboygan, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 661
Blinatumomab Consolidation in Real World
for
B-Cell Acute Lymphoblastic Leukaemia
Location: Milwaukee WI, Chicago IL, Philadelphia PA,
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT07117136
Recruiting
Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
for
Aortic Arch Aneurysm, Aortic Arch Dissection,
Location: Milwaukee WI, Chicago IL, Ann Arbor MI, Cleveland OH,
Sponsor: Artivion Inc.
Sex: All
Age: 18 - 70+
Code: NCT07089576
Recruiting
Teclistamab-Daratumumab in AL Amyloidosis
for
Amyloid Light-chain Amyloidosis
Location: Milwaukee WI, New York NY
Sponsor: Rajshekhar Chakraborty, MD
Sex: All
Age: 18 - 70+
Code: NCT07110844
Phase2, Recruiting
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
for
Breast Neoplasms
Location: Milwaukee WI, Royal Oak MI, Urbana IL, Detroit MI,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07173751
Phase3, Recruiting
Mechanisms of Improving Fecal Continence Muscles Motor Function
for
Fecal Incontinence
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT06532123
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Non-invasive Prediction of EArly Cardiac rEjection
Location: Milwaukee WI, Chicago IL, Ann Arbor MI, Indianapolis IN,
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 6 - 25
Code: NCT07770659
Recruiting
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
for
Myeloproliferative Neoplasms
Location: Milwaukee WI, Chicago IL, Baltimore MD, Chapel Hill NC,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07008118
Phase1, Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer